Primary Objective: What are the consequences of irradiation for the human jaw bone and oral mucosa on a macroscopic, microscopic and molecular level?Can possible prognostic factors be identified for the occurrence of peri-implantitis, dental implant…
ID
Source
Brief title
Condition
- Therapeutic and nontherapeutic effects (excl toxicity)
- Head and neck therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
- Differences in histomorphometric parameters between healthy and irradiated
human jaw bone and jaw bone involved in an osteoradionecrosis lesion.
- Gene expression profiles of irradiated oral mucosa and oral mucosa associated
with an osteoradionecrosis lesion compared to healthy oral mucosa.
- Differences in cell surface characteristics (microplication and microvilli)
of irradiated and non irradiated oral mucosa and oral mucosa associated with an
osteoradionecrosis lesion.
Secondary outcome
- Abnormalities in histomorphometric parameters in jaw bone of smokers in the
control group and non-irradiated patients treated for a malignancy of the oral
cavity compared to non-smoking controls.
- Genexpressieprofiles in oral mucosa of smokers in the control group as
opposed to non-smokers and gene expression profiles of non-irradiated patients
treated for a malignancy of the oral cavity compared to non smoking controls.
- Cell surface characteristics (microplications and microvilli) in the oral
mucosa of smokers in the control group and in non-irradiated patienst treated
for a malignancy of the oral cavity compared to non-smokers.
These parameters are important to filter the contributing effect of smoking and
malignancy to oral tissue alterations in irradiated oral cancer patients.
Background summary
Each year, on average, 520 new cases of cancer of the oral cavity are diagnosed
in the Netherlands. This represents 0,9% of all newly diagnosed cases of
cancer. The treatment for oral cancer consists, depending on localisation and
staging, of surgery and/or radiotherapy(1). Oncologic resections in oral cancer
patients are often complex and mutilating. Reconstruction with
osteomyocutaneous flaps are commonly performed in these patients. This is a
major surgical procedure that has extensive consequences for oral functions
such as swallowing, chewing and speech. Many patients need oral rehabilitation
after the treatment for oral cancer, which consists of logopedia and dental
prosthetics.
Oral rehabilitation with dental implants of patients treated for oral cancer is
a meaningful postoperative procedure to increase quality of life(2). Dental
implant surgery is often indicated in these patients to create a sound fitting
prosthesis in the altered anatomy of the reconstructed oral cavity. Though
radiotherapy plays an important role in the treatment of head and neck
malignancies, side effects occur that have a major impact on the final results
of oral rehabilitation. Irradiation of the oral cavity is known to give acute
and chronic adverse local effects such as mucositis, xerostomia, hypogeusia,
trismus, radiation caries, candidiasis and osteoradionecrosis(3).
Osteoradionecrosis (ORN) is a severe complication and is characterized by a
non-healing area of exposed bone of at least three months duration(4). ORN is
associated with pain, drainage and fisteling of the mucosa or skin and usually
has a high morbidity. In advanced stages, ORN typically requires surgical
resection and reconstruction. Its incidence in de mandible is between 2-22% of
irradiated oral cancer patients. Factors that are thought to affect the
development of ORN include site and size of tumour, dose of irradiation, type
of resection, trauma (dental extractions), infection, immune deficiencies and
malnutrition(5). Placement of dental implants increases the risk of ORN.
Placing dental implants in irradiated tissue therefore is a clinical challenge.
Implant loss is observed in up to 24% of these patients(6).
Little is known about the etiology of ORN. During the past 80 years a number of
theories have been proposed, with consequent implications for its treatment. In
1983, Marx proposed the hypoxic-hypocellular-hypovascular theory: after
irradiation hypoxic-hypocellular-hypovascular tissue is formed, and breakdown
of this tissue driven by persistent hypoxia can cause a chronic non-healing
wound(7). This theory formed the basis of the use of hyperbaric oxygen therapy
for the treatment of ORN. Conflicting opinions about its efficacy exists, which
is reflected in the literature(8).
In 2004 another hypothesis was proposed: that of the fibro-atrophic process. In
this model, three successive clinical and histopathological phases can be
distinguished: a pre-fibrotic aspecific inflammatory phase, a constitutive
fibrotic cellular phase, and a matrix densification and remodelling phase,
possibly ending in terminal tissular necrosis(9). In the fibrotic process
different cytokines and growth factors are thought to play a role, such as
TNF-*, PDGF, FGFb, IL1,4 and 5, TGF*-1 and CTGF. TGF-*1 has been associated
with different fibrotic processes such as atherosclerosis, kidney, liver and
lung fibrosis and is thought to play a key role in post-radiation fibrosis. The
exact cascade of events and role of different cytokines and growth factors in
this process has not yet been clarified.
In order to avoid or decrease irradiation-induced complications, it is of vital
importance to get more insight in the histological and molecular background of
the effects of irradiation on oral soft and hard tissues. Previous studies have
focused on the effects of irradiation on bone tissue. Radiogenic bone
damage(10-17) and osseo-integration of implants in irradiated bone(18-22) has
been studied in various animal models. In irradiated rat mandible models,
diminished bone volume and mineral apposition rate were observed al well as
diminished numbers of osteoclasts and osteoblasts, hypovascularity, presence of
fibrosis and inflammation and unusually high presence of osteoclasts in
extraction sockets10,11.With regards to osseointegration of implants in animal
models, a dose dependent relationship between radiotherapy and osseointegration
is observed: the osseointegration diminishes with increasing dose of
irradiation(18-22).
This relationship has also been described in a retrospective analysis of dental
implant survival after radiotherapy in humans(23). Although the data with
regard to irradiated bone are not conclusive, it has clearly been shown that
after irradiation, there is a higher chance of failure of dental
implants(6,23-24). However evidence for a dose-dependent relationship of
irradiation dosage and implant failure in humans is conflicting. One systematic
review on dental implant osseointegration after radiotherapy suggests that
increased implant loss occurs in patients that received a radiation dose that
exceeds 50 Gray(24), whereas another describes no dose-dependent relationship
with regards to osseointegration(6). A possible contributing factor to these
conflicting reports is that radiotherapy went through a rapid development over
the past decades with respect to dosimetry and strategies to keep normal
anatomical structures outside the irradiation field(25-27). It has been
suggested that these more sophisticated methods of irradiation contribute to
lower incidence of ORN(27). However, improved dosimetry in radiotherapy regimes
has not been identified as an independent factor for reducing the risk of ORN
or implant loss in clinical setting with long-term follow-up.
In the current literature, no studies focusing primarily on histological and
histomorphometric changes in irradiated human jaw bone could be found. One
study has performed a histological and histomorphometrical evaluation of bone
tissue adjacent to post-mortem retrieved dental implants from irradiated head
and neck cancer patients(28). This study focused on osseointegration by
measuring bone-implant contact. In the retrieved dental implants, lowered
metabolic activity of bone tissue and diminished bone-implant contact was
observed. This finding suggests that irradiation has effect on bone metabolism
in human jaw bone that can possibly be objectified by performing histological
and histomorphometrical analysis of irradiated human jaw bone as proposed in
this research protocol.
One of the key processes of ORN is thought to be the altered expression of
inflammation mediators and growth factors. In order to assess altered
expression of genes in tissue a micro-array analysis can be performed(29). A
micro-array analysis detects levels of different strands of mRNA in a tissue
sample. When a gene is expressed, mRNA is transcribed from DNA and serves as a
template for protein synthesis. Because an mRNA transcript is an exact copy of
a corresponding DNA coding region, genomic analysis at the mRNA level can be
used as a measure of gene expression. Previous studies using microarray
analysis in oral cancer patients have mainly focused on gene expression of
tumor cells(30-33). Few studies focusing on the effect of irradiation on the
tissues surrounding the tumor could been found in the literature. In one study,
a microarray analysis of dermal keratinocytes in radiation induced skin wounds
demonstrated altered expression of keratins, growth factors and matrix
metalloproteinases(34). Another study demonstrated altered gene expression in
peripheral blood cells following adjuvant chemoradiation therapy for head and
neck cancer(35). Late changes in cutaneous gene expression after radiotherapy
for head and neck cancer were demonstrated in microarray analysis of
irradiated, non-ulcerating skin specimen harvested at secondary corrective
surgical procedure(36). However, expression profiles of oral tissues involved
in osteoradionecrosis have not yet been studied.
In the field of rheumatology, the microarray technique has been used to
identify expression patterns of inflammatory mediators in rheumatoid arthritis
patients, that could to some extent be correlated with clinical parameters such
as disease activity and biomarkers in peripheral blood(37,38). This finding
suggest that certain phenotypes of immune response can predispose for
pathologic inflammatory conditions such as auto-immune diseases. According to
the fibro-atrophic theory, ORN, like rheumatoid arthritis is considered a
pathologic inflammatory response. It is possible that a specific *fingerprint*
of inflammation response, as found in rheumatoid arthritis patients, can play a
part in the etiology of ORN. Therefore, it will be interesting to perform a
gene expression microarray analysis of irradiated human mucosa versus human
mucosa involved in ORN.
The effects of irradiation on mucosal cells can be observed in scanning
electron microscopy. Scanning electron microscopy (SEM) studies have shown that
the outer surface of epithelial cells of the oral mucosa is covered by numerous
microplicae (microvilli/ microprojections)39. Several functions have been
attributed to this characteristic structure. It is thought to maximize the
uptake of oxygen and nutrients and facilitate the movement of metabolic
products across the outer cell membrane. Microplicae functions are thought to
be closely related to glycocalyx and extracellular matrix (ECM) sturcture.37
Although the exact function of microplicae remains unclear, it is widely
accepted that this structure is essential to maintain intact tissue
physiology40. Scanning electron microscopy of irradiated buccal human mucosa
swaps have shown loss of microplication and microvilli of the mucosal
cells41,42, however, cells retrieved from buccal smears are subject to bias due
to contamination and lack of tissue structure. It would be a great value to
investigate the effects of irradiation on the mucosal tissue in humans by
performing scanning electron microscopy on mucosal tissue specimen surfaces as
opposed to buccal swaps, hereby creating an image that also contains the
intercellular junctions, maintaining normal tissue architecture and diminishing
contamination with mucus and bacteria.
Hyaluronan (HA) is a multifunctional glycosaminoglycan that forms the
structural basis of the extracellular matrix (ECM). Hyaluronan synthases (HASs)
are plasma membrane enzymes that simultaneously elongate, bind, and extrude the
growing hyaluronan chain directly into extracellular space. Hyaluronan (HA) is
thought to promote cancer cell growth and migration43. HA has been shown to be
a prognostic marker in oral squamous cell carcinoma, and a diminished intensity
of HA staining is associated with poor survival44. HASs play a role in wound
healing and in some oral diseases45. The role of hyaluronan (HA) in irradiated
oral tissues has not yet been researched. Altered expression of hyaluronan
could have structural effects on the extracellular matrix, that we assume does
not only play a role in invasive cancer growth, but also in the altered wound
healing in irradiated mucosa.
Our hypothesis is that peri-implantitis, implant failure and ORN in irradiated
oral cancer patient is caused by abnormalities in both hard and soft oral
tissues, possibly with similar molecular mechanisms. This study aims to
investigate the process of irradiation-induced changes in both jaw bone and
oral mucosa. By investigating gene expression of inflammatory markers,
histological properties and cell surface and extracellular matrix changes of
the irradiated versus non-irradiated oral tissues we aim to find clues to
predict future peri-implantitis, implant loss and ORN.
In the Department of Oral and Maxillofacial Surgery (OMFS) of the VU University
medical center in Amsterdam there is a longstanding and large experience with
the reconstruction and oral rehabilitation with dental implants in oral cancer
patients. During many years there has been a collaboration in the field of bone
research between the department of oral and maxillofacial surgery and the
department of endocrinology. There are strong bonds with the Finnish experts in
the field irradiated oral tissues, especially at electron microscopy level.
Literature
1. Vereniging integrale kankercentra (VIKC). Landelijke richtlijn mondholte- en
oropharynxcarcinoom, versie 1.4 (2004). VIKC: Utrecht. [online]
http://www.oncoline.nl. (visited: 6-12-2010)
2. Hollister MC, Weintraub JA. The association of oral status with systemic
health, quality of life, and economic productivity. J Dent Educ 1993;57:901-12.
3. Bonan PRF, Kaminagakura E, Pires FR, Vargas, PA, de Almeida OP.
Histomorphometry and immunohistochemical features of grade I (WHO) oral
mucositis. Oral Dis 2007;13:170-6.
4. Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws *
a current overview * part 1. Oral Maxillofac Surg 2010;14:3-16.
5. Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of
it's pathophysiology and treatment. J Oral Maxillofac Surg 2008;46:653-60.
6. Javed F, Al-Hezaimi K, Al-Rasheed A, Almas K, Romanos GE. Implant survival
rate after oral cancer therapy: a review. Oral Oncol 2010:46;854-859.
7. Marx R. Osteoradionecrosis: a new concept of it*s pathophysiology. J Oral
Maxillofac Surg 1983;41:283-8.
8. Spiegelberg L, Djasim UM, van Neck HW, Wolvius EB, van der Wal KG.
Hyperbaric oxygen therapy in the management of radiation induced injury in the
head and neck region: a review of the literature. J Oral Maxillofac Surg
2010;68:1732-9.
9. Delainan S, Lefaix JL. The radiation induced fibroatrophic process:
therapeutic perspective via the anti-oxidant pathway. Radiother Oncol
2004:73;119-31.
10. Cohen M, Nishimura I, Tamplen M, Hokugo A, Beumer J, Steinberg ML, Suh JD
et al. Animal model of radiogenic bone damage to study mandibular
osteoradionecrosis. AM J Otolaryngol 2010 (epub ahead of print)
11. Fenner M, Park J, Schulz N, Amann K, Grabenbuer GG, Fahrig A, Karg J et al.
Validation of histologic changes induced by external radiation in mandibular
bone. An experimental animal model. J Cran Maxillofac Surg 2009;38:47-53.
12. Niehoff P, Springer IN, Yahya A, Lange A, Marget M, Roldán JC Köppe K et
al. HDR brachytherapy irradiation of the jaw * as a new experimental model of
radiogenic bone damage. J Cran Maxillofac Surg 2008;36:203-9
13. Zhang WB, Zheng LW, Chua D, Cheung LK. Bone regeneration after radiotherapy
in an animal model.
14. Jacobsson M, Albrektsson T, Turesson I. Dynamics of irradiation injury to
bone tissue. Acta Radiol Oncol 1985;24:343-50.
15. Yachouh J, Breton P, Roux JP, Goudot P. Osteogenic capacity of vascularised
periosteum: an experimental study on mandibular irradiated bone in rabbits. J
Plast Reconst Aes 2010 (epub ahead of print)
16. Lerouxel E, Moureau A, Bouler JM, Guimelli B, Daculsi G, Weiss P, Malard O.
Effects of high doses of ionising radiation on bone in rats: a new model for
evaluation of bone engineering. Br J Oral Maxillofac Surg 2009;47:602-7.
17. Verdonck HWD, Meijer GJ, Nieman FH, Stoll C. Riediger D, de Baat C.
Quantitative computed tomography bone mineral density measurements in
irradiated and non-irradiated minipig alveolar bone: an experimental study.
Clin Oral Impl Res 2008:19;464-8.
18. Asikainen P, Klemetti E, Kotilainen R, Vuillemin T, Sutter F, Voipio HM,
Kullaa A.
Osseointegration of dental implants in bone irradiated with 40, 50 or 60 Gy
doses
Clin Oral Impl Res 1998; 9 : 20-25.
19. Asikainen P, Kotilainen R, Vuillemin T, Sutter F, Viopio HM, Kullaa A.
Osseointegration of dental implants in radiated mandibles: An experimental
study with beagle dogs. J of Oral Implantology 1991; 17: 48-54.
20. Matsui Y, Ohno K, Michi K, Tachikawa T. Histomorphometric examination of
healing around hydroxylapatite implants in 60Co-irradiated bone. J Oral
Maxillofac Surg 1994;52:167-72.
21. Ohrnell LO, Branemark R, Nyman J, Nilsson P, Thomsen P. Effects of
irradiation on the biomechanics of osseointegration. Scan J Plast Reconstr Hand
Surg 1997:31;281-93.
22. Johnsson AA, Sawaii T, Jacobsson M, Granström G. A histomorphometric and
biochemical study of the effect of delayed titanium implant placement in
irradiated rabbit bone. Clin Implant Dent Res 2000;2:42-9.
23. Granström G. Osseointegration in irradiated cancer patients: an analysis
with respect to implant failures. J Oral Maxillofac Surg 2005;63:579-85.
24. Ihde S, Kopp S, Gundlach K, Konstantinovic VS. Effects of radiation therapy
on craniofacial and dental implants: a review of the literature. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod 2009;107:56-65.
25. Struder G, Gratz KW, Glanzmann C. Osteoradionecrosis of the mandibula in
patients treated with different fractionations. Strahlenther Onkol
2004;180:233-40.
26. Puri DR, Chou W, Lee N. Intensity-modulated radiation therapy in head and
neck cancers: dosimetric advantages and update of clinical results. Am J Clin
Oncol 2005;28:415-27. Ben-David MA, Diamante M, Radawski JD, Vineberg KA,
Stroup C, Murdoch-Kinch CA, Zwetchenbaum SR et al. Lack of osteoradionecrosis
of the mandible after intensity-modulated radiotherapy for head and neck
cancer: likely contributions of both dental care and improved dose
distributions. In J Rad Oncol Biol Phys 2007;68:396-402.
28. Bolind P, Johansson CB, Johansson J, Granström G, Albrektsson T. Retrieved
implants from irradiated sites in humans: a histologic/histomorphometric
investigation of oral and craniofacial implants. Clin Implant Dent Res
2006;8:142-50.
29. Kuo WP, Whipple ME, Sonis ST, Ohno-Machado L, Jenssen TK. Gene expression
profiling by DNA microarrays and its application to dental research. Oral
oncology 2002;38:650-6.
30. Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen MW. Tissue
microarray - a high throughput analysis in head and neck cancer. J Oral Pathol
Med 2008;37:166-76.
31. Coutinho-Camillo CM, Laurenço SV, Nishimoto IN, Kowalski LP, Soares FA.
Caspase expression in oral squamous cell carcinoma. Head Neck J Sci Spec 2010
12 nov (epub ahead of print)
32. Tomoika H, Morita K, Hasegawa S, Omuro K. Gene expression analysis by cDNA
microarray in oral squamous cell carcinoma. J Oral Pathol Med 2006;35:206-11.
33. Chen CH, Chioen CY, Huang CC, Hwang CF, Chuang HC, Fang FM, Huang HY et al.
Expression of FLJ10540 is correlated with aggressiveness of oral cavity
squamous cell carcinoma by stimulating cell migration and invasion through
increased FOXM1 and MMP-2 activity. Oncogene 2009;28:2723-37.
34. Goessler UR, Bugert P, Kassner S. Stern-Straeter J, Bran G, Sadick H,
Hörmann K, Riedel F. In vitro analysis of radiation-induced dermal wounds.
Otolaryng head neck 2010;142:845-50.
35. Sonis S, Haddad R, Posner M, Watkins B, Fey E, Morgan TV, Mookanamparambil
et al. Gene expression changes in peripheral blood cells provide insight into
the biological mechanisms associated with regimen/related toxicities in
patients being treated for head and neck cancers. Oral Oncology 2007;43:289-300.
36. Mueller CK, Thorwarth M, Schultze-Mosgau S. Late changes in cutaneous gene
expression patterns after adjuvant treatment of oral squamous cell carcinoma
(OSCC) by radiation therapy. Oral surg oral med oral pathol oral radiol endod
2010;109:694-9.
37. van der Pouw Kraan TCTM, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets
TJM, Kraan MC, Fero M et al. Rheumoatoid arthritis is a heterogeneous disease.
Evidence for differences in the activation of the STAT-1 pathway between
rheumatoid tissues. Arhtritis Rheum 2003;48:2132-45.
38. van Baarsen LGM, Wijbrandts CA, Trimmer TCG, van der Pouw Kraan TCTM, Tak
PP, verweij CL. Synovial tissue heterogeneity in rheumatoid arthritis in
relation to disease activity and biomarkers in peripheral blood. Arthritis
Rheum 2010;62:1602-7.
39. Kullaa-Mikkonen A. Scanning electron microscopic study of surface of human
oral mucosa. Scand J Dent Res 1986;94:50-6.
40. Koufakis DI, Karabatsas CH, Sakkas LI, Alvanou A, Manthos AK, Chatzoulis
DZ. Conjunctival surface changes in patients with Sjögren*s syndrome: a
transmission electron microscopy study. Invest Ophthalmol Vis Sci 2006;47:541-4.
41. Johnson ME, Murphy PL. Changes in the tear film and ocular surface from dry
eye syndrome. Prog Retin Eye Res 2004;23:449-74.
42. Robertson AG, Wilson P, Wilson DJ, Carr KE, Hunter I. Microplication
patterns on human buccal epithelia following radiotherapy: a scanning electron
microscopic analysis. J Submicrosc Cytol 1987;19: 515-21.
43. Soames JV, Macleod RI. Effects of radiotherapy on oral epithelium.
Quantitative cytology using light and scanning electron microscopy. Anal Quant
Cytol Histol 1995;17:389-96.
44. Tammi RH, Kultti A, Kosma VM, Pirinen R, Auvinen P, Tammi MI. Hyaluronan in
human tumors: pathobiological and prognostic messages from cell-associated and
stromal hyaluronan. Semin Cancer Biol 2008;18:288-95.
45. Kosunen A, Ropponen K, Kellokoski J, Pukkila M, Virtaniemi J, Valtonen H,
Kumpulainen E, Johansson R, Tammi R, Tammi M, Nuutinen J, Kosma VM. Reduced
expression of hyaluronan is a strong indicator of poor survival in oral
squamous cell carcinoma. J Oral Oncol 2004;40:257-63.
Study objective
Primary Objective:
What are the consequences of irradiation for the human jaw bone and oral mucosa
on a macroscopic, microscopic and molecular level?
Can possible prognostic factors be identified for the occurrence of
peri-implantitis, dental implant loss and/or ORN in irradiated patients with
oral cancer?
Is it possible to enhance the treatment decisions and prognoses of patients
with dental implants in reconstructive surgery?
Secondary Objective(s):
1. By performing histomorphometric analysis and micro-CT scanning of the
irradiated bone samples retrieving data on:
- Histological features of irradiated, osteoradionecrotic and 'control' bone *
Histology
- Number and size of blood vessels * Histology
- Number of osteoblasts per tissue area (N.Ob/T.Ar, cells/mm2), osteoclasts per
surface area (N.Oc/T.Ar, cells/mm2), osteocytes (N.Ot/Md.Ar. Cells/0,01 mm2)
and empty lacunae per mineralized surface area (N.Lac/Md.Ar. Cells/0,01 mm2) *
Histomorphometry
- Number of osteocytes that show signs of apoptosis (N.Apopt/Md.Ar. Cells/0,01
mm2) * Immunohistochemical staining of cleaved PARP
- Trabecular width (Tb.Wi., um) * Histomorphometry
- Trabecular thickness (Tb.Th. , um) * Micro CT
- Osteoid width (O.Wi., um) * Histomorphometry
- Osteoid thickness (O.Th, um) * Micro CT
- Absolute osteoid volume (OV/TV, %) * Micro CT
- Relative osteoid volume (OV/BV, %) * Micro CT
- Resorption surface - Histology
- Labeled surface (mineral apposition rate) (tertracycline labeling) *
Fluorescence Microscopy
- Surface area of bone, fibrosis, necrosis and marrow * Histology
- Presence of inflammatory cells/macrophages - Histology
- Calculating bone volume (BV), tissue volume (TV) and vital bone volume
(BV/TV, %) * Micro-CT
- Anisotropy (direction of trabecles) (Tr.Pf) * Micro CT
- Differences in types of irradiated bone (after surgery, depending on
reconstruction, the jaw bone can consist of original mandibular/maxillar, or
transplanted autograft (fibula, crista) bone) * Histology
2. By performing micro array analysis on irradiated mucosa, retrieving data on
- Gene-expression of proteins (focusing on cytokines and growth factors) in
post-cancer non-irradiated, post cancer irradiated and osteoradionecrotic
tissue compared to healthy smoking an non-smoking controls
- Determine what proteins are differently expressed in clinically evident
osteoradionecrosis
- Determine whether different expression profiles exist between irradiated
patients
- In case these different expression profiles are found, correlate these with
clinical data, investigating whether certain expression profiles in irradiated
tissue predispose for developing peri-implantitis, ORN and dental implant loss
- Significantly differently expressed inflammatory proteins, growth factors and
cytokines can be investigated on tissue level with immunohistochemistry
analysis to assess presence and localisation in the tissue.
3*. By performing scanning electron microscopy and different non-invasive
microspectrosopy on healthy, post-cancer, post-cancer irradiated and
post-cancer irradiated radionecrotic mucosa and bone tissue specimens,
obtaining information about:
- Cell surface changes in oral cancer mucosa, irradiated mucosa and
osteonecrotic mucosa compared to healthy controls
- Changes in microplication/microvilli and their interaction with hyaluronan
biosynthesis
* This part of the research will be performed at the SIB-labs Laboratory of the
University of Eastern Finland, Kuopio, Finland.
Study design
Prospective observational study
Study burden and risks
Venapuncture for blood sampling is an invasive procedure which may cause slight
discomfort for the patient.
Tetracycline labeling of bone has a potential risk for adverse reactions that
are known for tetracycline use and are described in the 'farmacotherapeutisch
kompas'.
De Boelelaan 1118
Amsterdam 1081 HZ
NL
De Boelelaan 1118
Amsterdam 1081 HZ
NL
Listed location countries
Age
Inclusion criteria
Patients treated for cancer of the oral cavity receiving oral rehabilitation with dental implant surgery. (cases)
Patients treated for oral cancer with irradiation and dental implants, complicated by osteoradionecrosis.
Healthy subjects receiving implant surgery for missing dental elements. (controls)
Exclusion criteria
Age <18
Legal incapacity
Patients with impaired bone metabolism (e.g. haemodialysis, hyperparathyroidism, osteomalacia) (registration, no inclusion).
Patients having used systemic immunosuppressive medication up to three months prior to the dental implant surgery (registration, no inclusion).
Patients allergic to tetracycline will be excluded for the tetracycline labelling of bone analysis exclusively.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL34966.029.11 |